Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Latest news on ASTELLAS PHARMA INC
10/18 ASTELLAS PHARMA : Enters into a New Collaborative Research Agreement with TB All..
10/13 ASTELLAS PHARMA : U.S. FDA Grants Fast Track Designation to Astellas for Develop..
10/12 ASTELLAS PHARMA : Patent Issued for Method for Treating Premature Ejaculation an..
10/12 ASTELLAS PHARMA : Patent Issued for Pharmaceutical Composition for Oral Administ..
10/12 SEATTLE GENETICS : Astellas and Seattle Genetics Initiate Pivotal Trial of Enfor..
10/12 ASTELLAS PHARMA : U.S. FDA Grants Fast Track Designation to Astellas for Develop..
10/12 Astellas, Mitsubishi Tanabe Pharma, and Daiichi Sankyo Conduct 'JOINUS,' a Ne..
10/11 SEATTLE GENETICS : and Astellas Initiate Pivotal Trial of Enfortumab Vedotin for..
10/11 ASTELLAS PHARMA : U.S. FDA Grants Fast Track Designation to Astellas for Develop..
10/11 ASTELLAS PHARMA : and Seattle Genetics Initiate Pivotal Trial of Enfortumab Vedo..
10/11 ASTELLAS PHARMA : Mitsubishi Tanabe Pharma, and Daiichi Sankyo Conduct "JOINUS,"..
10/05 ASTELLAS PHARMA : Investigators from Astellas Pharma Release New Data on Genitou..
10/04 ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares
10/02 ASTELLAS PHARMA : and TOA EIYO Announce Co-promotion Agreement for Kiklin® Capsu..
10/02 ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares (pdf 311KB)
09/27 ASTELLAS PHARMA INC : ex-dividend day for interim dividend
09/21 PFIZER : and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Tr..
09/15 PFIZER : Astellas Announce Positive Top-Line Results From Phase 3 Prosper Trial ..
09/15 ASTELLAS PHARMA : U.S. FDA Accepts for Review Astellas' Supplemental New Drug Ap..
09/14 ASTELLAS PHARMA : Announces Launch of 'Keep on Dancing' Sweepstakes
09/14 ASTELLAS PHARMA : Reports on Immunosuppressive Agents Findings from Astellas Pha..
09/13 ASTELLAS PHARMA : U.S. FDA Accepts for Review Astellas' Supplemental New Drug Ap..
09/11 ASTELLAS PHARMA : Submits Supplemental New Drug Application for Approval of Addi..
09/08 ASTELLAS PHARMA : Announces Launch of 'Keep on Dancing' Sweepstakes
09/04 ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares
09/01 ASTELLAS PHARMA : Astella Announces Status of Acquisition of Own Shares (pdf 311..
08/31 ASTELLAS PHARMA : Researchers Submit Patent Application, "Pharmaceutical Composi..
08/31 ASTELLAS PHARMA : Farma Brasil Is Named One of the Best Companies to Work for in..
08/31 ASTELLAS PHARMA : First Patient Dosed in Phase 3 MORPHO Trial Evaluating Gilteri..
08/30 ASTELLAS PHARMA : Repatha@ Receives Approval for New 420mg Single-Dose Delivery ..
08/25 ASTELLAS PHARMA : Announces Personnel Changes and Organizational Changes
08/24 ASTELLAS PHARMA : Announces Personnel Changes and Organizational Changes(..
08/23 ASTELLAS PHARMA : First Patient Dosed in Phase 3 MORPHO Trial Evaluating Gilteri..
08/23 ASTELLAS PHARMA : FDA Approves IRWD`s Gout Drug, It`s A Thumbs Up For ALXN In EU..
08/22 ASTELLAS PHARMA : Rural Illinois Schools Offer New STEM Education Programs with ..
08/22 ASTELLAS PHARMA INC. : - First Patient Dosed in Phase 3 MORPHO Trial Evaluating ..
08/22 ASTELLAS PHARMA : First Patient Dosed in Phase 3 MORPHO Trial Evaluating Gilteri..
08/10 ASTELLAS PHARMA : Studies from Astellas Pharma in the Area of Diabetes Described..
08/03 ASTELLAS PHARMA : Recent Findings in Information and Data Management Described b..
08/01 ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares (pdf 329KB)
08/01 ASTELLAS PHARMA : LTL Pharma Succeeds Marketing Approval for "Nivadil® Tablets",..
07/28 ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 310KB)
07/28 ASTELLAS PHARMA : Reports First Quarter FY2017 Financial Results (pdf 434KB)
07/28 ASTELLAS PHARMA : Reports First Quarter FY2017 Financial Results
07/27 NEW TYPE 2 DIABETES STUDY FINDINGS R : ...
07/21 ASTELLAS PHARMA : U.S. FDA Grants Orphan-Drug Designation to Astellas for Develo..
07/13 ASTELLAS PHARMA : Supports the Northern Kyushu Heavy Rain Relief Efforts
07/12 ASTELLAS PHARMA : Presentation material for Press Conference on July 11th (1.76 ..
07/07 ASTELLAS PHARMA : Maruho Succeeds Marketing Approval for Anti-Atopic Dermatitis ..
07/06 ASTELLAS PHARMA : Submits Supplemental New Drug Application for Mirabegron for U..
07/05 ASTELLAS PHARMA : Named to FTSE4Good Sustainability Index for the Sixth Consecut..
06/30 Global Pertussis Vaccine Market 2017 - Sanofi Pasteur, Astellas Pharma, Life ..
06/24 ASTELLAS UK : Suspension from Membership of the ABPI to be Extended for 12 Month..
06/23 ASTELLAS PHARMA : president wants people to focus on lives saved by pharmaceutic..
06/22 ASTELLAS PHARMA : Drug company president wants people to focus on lives saved by..
06/21 ASTELLAS PHARMA : The Astellas Oncology C3 Prize Competition Returns for a Secon..
06/15 ASTELLAS PHARMA : and Pfizer Announce Amendment to Clinical Research Protocol fo..
06/15 ASTELLAS PHARMA : White & Case Advises Ogeda Shareholders on Sale to Astellas Ph..
06/10 PFIZER : Astellas, Pfizer Announce Amendment to Clinical Research Protocol for P..
06/09 ASTELLAS PHARMA : Researchers Submit Patent Application, "Treatment Regimen Tiac..
06/09 ASTELLAS PHARMA : Patent Application Titled "Pharmaceutical Composition for Oral..
06/09 ASTELLAS PHARMA : New Data from Astellas Pharma Illuminate Findings in Type 2 Di..
06/09 ASTELLAS PHARMA : and Pfizer Announce Amendment to Clinical Research Protocol fo..
06/08 ASTELLAS PHARMA : Announces Record Number of Abstracts Highlighting Breadth and ..
06/05 ASTELLAS PHARMA : Kyoto University and Astellas Inaugurate "Alliance Station" wi..
06/01 ASTELLAS PHARMA : Data on Proinsulin Detailed by Researchers at Astellas Pharma ..
06/01 ASTELLAS PHARMA : Announces Commitments to GHIT Fund Replenishment
05/25 ASTELLAS PHARMA : Announces Record Number of Abstracts Highlighting Breadth and ..
05/19 ASTELLAS PHARMA : MSD submits application for approval of type-2 diabetes drug c..
05/18 ASTELLAS PHARMA : Data on Pain Reported by Researchers at Astellas Pharma (Effec..
05/18 ASTELLAS PHARMA : Announces Decision to Discontinue ASP8273 Treatment and Close ..
05/18 NANOSTRING TECHNOLOGIES, INC. (NASDA : NSTG) Files An 8-K Other Events
05/15 ASTELLAS PHARMA : Announces Continuation of Performance-linked Stock Compensatio..
05/12 ASTELLAS PHARMA : Announces Decision to Discontinue ASP8273 Treatment and Close ..
05/11 ASTELLAS PHARMA : The Institute of Medical Science, the University of Tokyo, and..
1  2  3  4  5  6  7Next
Financials ( JPY)
Sales 2018 1 288 B
EBIT 2018 220 B
Net income 2018 185 B
Finance 2018 390 B
Yield 2018 2,38%
P/E ratio 2018 16,34
P/E ratio 2019 15,64
EV / Sales 2018 2,12x
EV / Sales 2019 2,06x
Capitalization 3 126 B
Chart ASTELLAS PHARMA INC
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Technical analysis trends ASTELLAS PHARMA INC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 1 544  JPY
Spread / Average Target 2,2%
EPS Revisions
Managers
NameTitle
Yoshihiko Hatanaka President, CEO & Representative Director
Yasumasa Masuda Chief Financial Officer
Mitsunori Matsuda Senior Executive Officer & President-Technology
Yoshiro Miyokawa Representative Director & Executive Vice President
Hironobu Yasuda Outside Director
Sector and Competitors
1st jan.Capitalization (M$)
ASTELLAS PHARMA INC-7.07%27 260
JOHNSON & JOHNSON18.42%377 880
NOVARTIS13.23%225 650
ROCHE HOLDING LTD.5.20%217 022
PFIZER11.88%215 576
MERCK AND COMPANY7.68%172 423